13      0

WOCN Continuing Education

Breaking Bad: Pharmacologic Impact of Medications on Wound Healing

Feb 24, 2017 12:00am ‐ Feb 24, 2022 11:55pm

Expiration Date: Feb 24, 2022

Credits: None available.

Standard: $25.00
Members: $0.00


Release Date: 2/24/2017
Expiration Date: 2/24/2022

Target Audience: RN, Nurse Practitioners, Health Care Professionals who work with WOC patients.

Credit Information:
ANCC and CBRN Accreditation Statements

The Wound, Ostomy and Continence Nurses Society is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

The WOCN Society was awarded Accreditation with Distinction, the highest recognition awarded by the American Nurses Credentialing Center's Accreditation Program.

Provider approved by the California Board of Registered Nursing, Provider Number CEP 15115.

DISCLAIMER: Accreditation refers to educational content only and does not imply ANCC, CBRN or WOCN endorsement of any commercial product or service.

To Receive Credit:

  1. Complete the activity in its entirety.
  2. Complete and submit the online course evaluation.
  3. Print out your certificate and/or save to your computer. It will also be saved to your CEC account.

Program Overview:
Wound care clinicians are familiar with the use of medications to treat or prevent skin and wound care problems. However they may be less aware that pharmacological therapies can cause adverse skin events and/or impair wound healing. This session will discuss pathomechanisms for adverse wound healing and skin changes and discuss clinical presentations.

Learning Outcomes:
Upon successful completion of this educational program, learners will be able to:

  1. Describe impact of pharmacological therapy on wound healing and skin integrity.
  2. Explain the patho-mechanisms of drug-induced skin reactions.
  3. Delineate drugs commonly and rarely causing wound healing impairment/adverse skin reactions.
  4. Describe clinical presentation and therapy for examplar drug-induced skin reactions.
  5. Discuss clinical practices mitigating drug effects.

, has disclosed relevant financial relationship or conflict of interest with commercial interest related directly to this educational activity.

Commercial Support or Non-Commercial Sponsorship:
There is no commercial support or non-commercial sponsorship for this activity.


  • Dr. Janice M. Beitz, PhD, RN, CS, CNOR, CWOCN-AP, CRNP, ANEF, FNAP, FAAN, Professor of Nursing and WOCNEP Director, Rutgers University Camden
Category: Wound


  • 0.89 - Contact Hours
  • 0.89 - Pharmacology

You must be logged in and own this session in order to post comments.